Ranbaxy buy triggers Sun Pharma’s Zenotech offer
18th April 2014
Sun Pharmaceutical Industries has made an open offer for Hyderabad-based firm Zenotech Laboratories.
Triggered by its purchase of Ranbaxy Laboratories on April 7. About 64% of Zenotech’s stocks are held by Ranbaxy and its parent company, Daiichi Sankyo, according to shareholding pattern as on March 31.
Read more at source article www.financialexpress.com